A Tailored Exercise Oncology Program for Neuro-Oncology Patients

计划入组 70 人 · 首次发布于 2021 年 4 月 5 日

Oncology Legal Navigation Study

计划入组 70 人 · 首次发布于 2026 年 3 月 2 日

Standard Follow-up Program Neuro-oncology Patients (SFP Neuro-Oncology)

计划入组 10,000 人 · 首次发布于 2024 年 7 月 30 日

ONCOLOGY(Gero)

Oncology (PostEra)

oncology program

Race Oncology

Belgium

NRG Oncology

United States

Verastem Oncology

United States

OmRx Oncology Launches Phase 2 Trial of Oral Checkpoint Inhibitor OX-4224 for NSCLC

OmRx Oncology Launches Phase 2 Trial of Novel Oral PD-L1 Inhibitor for NSCLC, Targeting Global Access Disparities

Oncology Pharmacists Expand Role in Value-Based Care Under Enhanced Oncology Model